Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 25Neoplasm Metastasis 6Metastatic Hormone-sensitive Prostate Cancer 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Stage I Prostate Adenocarcinoma 1Salivary Gland Neoplasms 1Recurrence 1Non-metastatic, Hormone naïve Prostate Cancer 1Neoplasms 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer 1Lymphatic Metastasis 1Insulin Resistance 1Adenocarcinoma of the Prostate 1

Interventions

luprolide acetate gel depot 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metastatic Castration-sensitive Prostate Cancer × Androgen Antagonists × Clear all
NCT05149131 2024-02-09

A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer

Bayer

Completed
960 enrolled
Genitourinary

Metastatic Castration-sensitive Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡